SEC Form 4 · accession 0001179110-17-011244
AbbVie Inc. · ABBV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard A Gonzalez
Officer — Chairman of the Board and CEO · Director
Period of report
Aug 7, 2017
Accepted (ET)
Aug 8, 2017 · 7:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001551152
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.01 par value | Aug 7, 2017 | M | 193,131 | $51.42 | A | 469,623 | D | |
| Common stock, $0.01 par value | Aug 7, 2017 | S | 6,779 | $71.005 | D | 462,844 | D | |
| Common stock, $0.01 par value | Aug 7, 2017 | S | 1,809 | $71.025 | D | 461,035 | D | |
| Common stock, $0.01 par value | Aug 7, 2017 | S | 100 | $71.055 | D | 460,935 | D | |
| Common stock, $0.01 par value | Aug 7, 2017 | S | 3 | $71.065 | D | 460,932 | D | |
| Common stock, $0.01 par value | Aug 7, 2017 | S | 6,200 | $71.05 | D | 454,732 | D | |
| Common stock, $0.01 par value | Aug 7, 2017 | S | 1,153 | $71.015 | D | 453,579 | D | |
| Common stock, $0.01 par value | Aug 7, 2017 | S | 1,800 | $71.06 | D | 451,779 | D | |
| Common stock, $0.01 par value | Aug 7, 2017 | S | 157,163 | $71.00 | D | 294,616 | D | |
| Common stock, $0.01 par value | Aug 7, 2017 | S | 1,100 | $71.045 | D | 293,516 | D | |
| Common stock, $0.01 par value | Aug 7, 2017 | S | 2,602 | $71.04 | D | 290,914 | D | |
| Common stock, $0.01 par value | Aug 7, 2017 | S | 3,158 | $71.02 | D | 287,756 | D | |
| Common stock, $0.01 par value | Aug 7, 2017 | S | 446 | $71.035 | D | 287,310 | D | |
| Common stock, $0.01 par value | Aug 7, 2017 | S | 9,618 | $71.01 | D | 277,692 | D | |
| Common stock, $0.01 par value | Aug 7, 2017 | S | 1,200 | $71.03 | D | 276,492 | D | |
| Common stock, $0.01 par valueF1 | holding | — | — | — | 4,600 | I | By spouse | |
| Common stock, $0.01 par valueF1 | holding | — | — | — | 450 | I | By step-daughter | |
| Common stock, $0.01 par valueF1 | holding | — | — | — | 450 | I | By step-son |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F2 | $51.42 | Aug 7, 2017 | M | 193,131 | D | Feb 20, 2017 | Feb 19, 2024 | Common stock | 193,131 | 0 | D |
Explanation of responses
- F1The reporting person disclaims beneficial ownership of these securities.
- F2Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
Remarks
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).